Gene products coded for by the D and/or K regions of the major histocompatibility complex (MHC)' must play a determinant part in the interaction between immune cytolytic T lymphocytes (CTL) and their virus-infected or hapten-modified syngeneic stimulating and targets cells, since a high level of specific cytolysis occurs only when both the CTL and the target cells possess shared H-2D and]or H-2K antigens (1) (2) (3) (4) . The same phenomenon exists in the interaction between T-killer lymphocytes and syngeneic virusinduced tumor cells. This has been demonstrated both by immunization with oncogenic viruses (5) (6) (7) (8) and by grafl~ of syngeneic virus producer lymphoma cells (9) (10) (11) . In murine sarcoma virus (MSV) tumors and in Friend virus (FLV) leukemias, such H-2 restrictions of CTL activity have been shown to occur during both primary in vivo response (5, 6, 9) and secondary in vitro CTL restimulation (12) . Some degree of cytolysis exists also against H-2 incompatible tumor cells induced by the same viruses especially when strong responses are elicited. However quantitative experiments, with different effector to target cell ratios, demonstrate that such activity is 10-100 times weaker than that shown against H-2 compatible targets (12, 13) . Though the exact role of H-2 directed molecules in the anti-MSV and anti-FLV reactions by syngeneic CTL is unknown, the hypothesis that the reactions are directed against altered self specificities as in other systems (1-4) appears more probable than the one requiring a double contact and sometimes designated as the intimacy theory (5, 9, 10, 13) . In most systems both Ho2D and H-2K have been implicated (1-4) but a predominant role of H-2K in vaccinia viral infection (14) and of H-2D in other systems (11, (15) (16) (17) (18) (19) including tumor antigens (11) has been noted.
In the MSV tumor, we previously observed that one or the other regions of the MHC was involved depending on the H-2 haplotype (13) . A more precise understanding of the respective roles of H-2D, H-2K, and possibly other molecules under the control of the MHC is necessary to determine the biological used to obtain monospecific anti-H-2D b (adsorption into 5R) or anti-H-2K b (absorption into 4R). (b) Antisera were also prepared so that they were directed only against H-2Db: (B10. Blocking by Anti-H-2 Sera. Target cells incubated for 20 min at 4°C with 1/2 to 1/16 diluted anti-H-2 or anti-Ia immune sera were used in the CRT, as described above, without further washing. Controls were: (a) target cells incubated with nonimmune sora from the same mouse line. (b) Target cells incubated with the immune serum and tested in the CRT with normal (nonimmune) syngeneic lymphocytes. The fnal activity of the immune CTL was calculated by comparing the chromium release in the presence of either immune lymphocytes or normal lymphocytes, the target cells being in both cases incubated with the immune serum.
Results

Cytolysis of Lymphoma Cells by In Vivo-Primed Anti-MSV Spleen Cells from Different H-2 Recombinant Lines
STUDY IN THE H-2 ~ HAPLOTYPE. Tumors were induced in different inbred strains by i.m. inoculation with 1-to 2-mo-old mice with MSV. When the tumor size was maximal, at which point CTL activity is also expected to be maximal (21) , spleen cells were sampled and tested in the CRT against different H-2 b lymphomas. The results were as follows: (a) effecter cells from B6 or B10 mice (H-2 b) were strongly cytolytic against all six FMRGi(+)1-1-2 b lymphomas tested (Table I) . In other words the CTL of B6 or B10 mice functioned with equal efficiency regardless of whether the target lymphomas were from B6 or BALB/B origin, or induced by Rauscher, Friend, Graffi, Tennant, or Moloney viruses. (b) The same effector cells were not reactive against the nonviral EIA lymphomas (not shown). (c) As previously reported (5, 13) BALB/c or B10.D2 effector cells were unable to lyse any to the H-2 b lymphoma targets. (d) A pattern of reactivity similar to that found in B6 and B10 was also detected with effector cells from HTG, 2R, 4R, and WB mice (Table I) . Mice of all of these strains share some part of the D end of the MHC with the H-2 ~ lymphomas. This common part is limited to the D region in 2R and WB. The same situation also exists with HTG, which in addition differs from the B6 and BALB/B targets by numerous non-H-2 antigens. It has been found previously however that the non-H-2 genes do not play a role in the CTL/target cells interactions (5, 13) . It must therefore be concluded that an identity limited to the D b region is sufficient for a strong CTL activity against H-2 b viral lymphomas. (e) Anti-MSV-CTL from 5R and HTI were unable to kill any 1-1-2 b targets, or were marginally efficient. This suggests that H-2K b or other molecules coded by the K region are not involved in the anti-MSV CTL activity. This probably holds also for Ia antigens since the K, I, and S regions are identical in HTI effectors and in targets of BALB/B or B6 origin differences being restricted to the D region. 
¢)
One can conclude therefore that an identity of the CTL and the targets limited to the D region is both necessary and sufficient to allow lytic interactions. In all these experiments the complete and specific abrogation of the spleen cell activity by anti-Thy 1.2 serum and complement was verified showing that the effector cells are T cells (results not shown). This is in agreement with previous results obtained in the MSV system (23, 24) . The presence of both normal H-2K b and H-2D b antigens on the six FMRGi (+) lymphomas employed was shown by their sensitivity to lysis by allogeneic anti-H-2K b CTL or anti-H-2D b CTL.
STUDY IN THE d HAPLOTYPE. The same type of experiments were done by using three FMRGi (+) H-2 d lymphomas (Table II) . These showed that (a) BALB/B (I-I-2 b) CTL which were very efficient against H-2 ~ targets (Table I and (13) . This apparent discrepancy was observed more frequently and with a higher level of lysis with B10.A anti-MSV effector lymphocytes. However these exceptional reactions could not be abolished by anti-Thy 1.2 treatment of the effector cells their pattern of specificity differed from the usual anti-MSV, or anti-FLV-CTL pattern. The B10.A spleen cells from anti-MSV immune animals were found to lyse t-I-2 d targets in about 25% of the experiments, but in these same experiments they showed a similar degree of activity for nonviral lymphomas, and also for viral but 1-1-2 incompatible tumors such as MBL2 (H-2b) . We therefore conclude that these reactions were directed against antigens other than those responsible for syngeneic anti-MSV reactions, and that such cytolysis being mediated by non-T cells, they are therefore not relevant to the response studied here.
On the whole it appears that T-cell-mediated cytolysis of H-2 d targets by anti-MSV spleen cells require that the effector cells possess the K end of the MHC identical to that of the target cells. It cannot be determined from these experiments if it is the K d or the I d regions or both which are concerned. It can however be concluded that the D region is not involved. The presence of normal nonmodifled H-2D d and H-2K d antigens at the cell surface was verified by the demonstration that all three of the H-2 d viral lymphomas used in these experiments are killed by allogeneic anti-H-2D d or anti-H-2K d CTL (Table II) . The lymphoid to targets ratio giving at 16 h 50~ specific chromium release (as compared to the maximum chromium release obtained by HCI minus the chromium release in controls) was calculated from curves plotting percent chromium release versus L/T ratios (log). It allowed us to calculate the number of cells necessary for one lyric unit and therefore the number of lytic units per million effector cells.
Cytolysis of H-2 b and H-2 d Viral Lymphomas by In Vitro
priming, displayed greatly increased activities after in vitro restimulation, and these activities remain virus specific, since nonviral L1210 cells are not lysed, and H-2 restricted, since the restimulated cells were unable to kill 1t-2 b targets. On the contrary the spleen cells of A.TH, HTI, and B10.A (5R) which were, ineffective in vivo, remained so after in vitro culture with Con A.
Blocking of the Anti-MSV-CTL Activity by Monospecific Anti-H-2 Serums. It has been shown previously that incubation of tumor cells with related anti-H-2 antibodies completely and specifically abolishes their sensitivity to cytolysis by syngeneic anti-MSV-CTL (5). This observation suggests a close
topographical relationship between H-2 molecules and viral antigens, supporting the altered self hypothesis. In the present experiments advantage was taken of this phenomenon to study the nature of the altered H-2 antigens of oncornaviruses induced lymphoma cells. After incubation with monospecific anti-H-2 antibodies of different origins, the lymphoma cells were tested in the CRT. Relatively weak activities were frequent in the positive controls of these experiments and are due to the short incubation periods used in the CRT tests (6 h).
STUDY IN THE H-2b HAPLOTYPE. Lymphoma cells of B6 or BALB/B (H-2 b)
were incubated with antisera reacting against the whole haplotype of the H-2 haplotype, or only against the products of the D or K regions and then exposed to syngeneic anti-MSV or anti-FLV-CTL. The results (Table IV) FMRGi (+) lymphomas tested (Table V) . On the whole the results from the above experiments (Table IV) perfectly able to function as target for allogeneic anti-H-2 CTL. These results suggest the existence of a specific interaction between a viral product and some molecule coded for by the MHC, these molecules differing with the H-2 haplotype.
The exclusive involvement of only one product of the MHC in the interaction between T-killer cells and syngeneic viral lymphomas is not the property of a given type C virus, since the nine tumors tested in these experiments were induced by five different agents: Friend, Rauscher, Moloney, Graffi, and Ten- 
Cytolysis of LSTRA (H-2 d) by Anti-MSV and Anti-H-2 d CTL Selective Effect of Specifically Directed Anti-H-2 Sera
LSTRA preincubation with:
Serums Specificity Percent specific chromium release* of the target cells in the presence of: nant leukemia-viruses. Moreover it was observed for both anti-MSV and anti-FLV attacker cells. It must however be noted that the five agents share several biological or pathological properties, and that the tumor cells tested have in common the FMRGi (+) serological specificity. One could suppose therefore that the same, or a closely related, viral protein is involved in all five cases in the interaction with the H-2 molecules. In other systems involving T-killer cells, it seems that normally both H-2D and H-2K specificity can function (1-4). In the H-2 b haplotype reactions involving the K b antigens have been reported in response to nononcogenic viruses infections (15) or during immunization against haptenmodified syngeneic cells (16) . In both cases, 5R effector cells were efficient against H-2 b targets, unlike the results described above in the MSV system. A predominant, or perhaps exclusive role of H-2D b seems to exist, however, in the interaction between H-2 b targets and allogeneic (but H-2 compatible) CTL reacting with minor histocompatibility antigens (17) , including the H-Y specificity (18) . In the 1-1-2 d and I-1-2 k haplotypes both K and D region-directed molecules seem to be involved in viral (19) and haptenic (16) systems. An exclusive involvement of a D region product was described in an antitumor response (11) whereas we have found an exclusive involvement of the K end of the t-I-2 d haplotype in oncornaviruses systems. We know, in addition, that a product of the K region is also strongly antigenic in the MSV system when H-2 k mice are tested (13) . A similar exclusive involvement of the K k specificity was reported in an anti-vaccinia viral immunization (14) . One can conclude therefore that the product of the MHC involved in the self alteration may depend on the nature of the CTL-triggering factor. In some cases only one product may be concerned and this may be especially true for antitumor responses (11, and present results) making these systems particularly useful for the study of the biological significance of the H-2 restriction phenomenon. These results show that the T-killer/target cells interaction in the MSV system involved some products of the H-2 complex which might be different with the various H-2 haplotypes and could possibly vary according to the antigenic specificity. A specific association of a viral product with a normal cellular structure, directed by the H-2 region during the viral budding could explain the observed results.
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